FLC
ORIA

Fifth Lane Capital’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Fifth Lane Capital’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33,500
Closed -$326K – 477
2022
Q1 		$326K Hold
33,500
– – 0.2% 130
2021
Q4 		$324K Buy
+33,500
New +$329K 0.19% 133

Other funds holding ORIA

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Fifth Lane Capital's ORIA Position: Q2 2022 in Review

Fifth Lane Capital sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2022, closing a stake of 33,500 shares — an estimated $326K sold.

Fifth Lane Capital first reported a position in ORIA in Q4 2021 and held it in 2 quarters. The position peaked at $326K in Q1 2022. 48 funds tracked by Wall St. Rank hold ORIA as of Q2 2022.

  • Fifth Lane Capital reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 33,500 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2022, an estimated $326K.
  • Fifth Lane Capital first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 2 quarters.
  • Fifth Lane Capital's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $326K in Q1 2022.
  • 48 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2022.

Based on Fifth Lane Capital's 13F filing for Q2 2022, filed 15 Aug 2022.